Immunomodulatory News and Research

RSS
Phase I study of triple drug combination shows promise in multiple myeloma patients

Phase I study of triple drug combination shows promise in multiple myeloma patients

Removing immunomodulatory protein improves symptoms of muscular dystrophy in mice

Removing immunomodulatory protein improves symptoms of muscular dystrophy in mice

CHMP recommends conditional marketing authorisation for Janssen’s daratumumab

CHMP recommends conditional marketing authorisation for Janssen’s daratumumab

Lenalidomide trials show potential for expanding lymphoma, leukaemia indications

Lenalidomide trials show potential for expanding lymphoma, leukaemia indications

Clinicoradiological syndromes allow rapid recognition of EV71 neurological problems

Clinicoradiological syndromes allow rapid recognition of EV71 neurological problems

SIRIUS supports single-agent daratumumab in refractory multiple myeloma

SIRIUS supports single-agent daratumumab in refractory multiple myeloma

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

HBI-8000 granted orphan drug designation in Japan for treatment of peripheral T-cell lymphoma

Scientists reveal major players in severe muscle damage caused by sepsis

Scientists reveal major players in severe muscle damage caused by sepsis

Exposure to farm animals, pets in early childhood modifies allergy-related immunological mechanisms

Exposure to farm animals, pets in early childhood modifies allergy-related immunological mechanisms

Combination treatment provides effective one-two punch against prostate cancer

Combination treatment provides effective one-two punch against prostate cancer

Virginia Tech researchers study how specific cytokine influences gene expression patterns in T helper cells

Virginia Tech researchers study how specific cytokine influences gene expression patterns in T helper cells

HUYA Bioscience International expands HBI-8000 clinical trials for breast cancer

HUYA Bioscience International expands HBI-8000 clinical trials for breast cancer

Continuous therapy improves multiple myeloma outcomes

Continuous therapy improves multiple myeloma outcomes

Experts shed light on the exciting field of therapy research for inflammatory diseases

Experts shed light on the exciting field of therapy research for inflammatory diseases

Transplanting mesenchymal stromal cells derived from amniotic membranes can benefit eye diseases

Transplanting mesenchymal stromal cells derived from amniotic membranes can benefit eye diseases

IP10 levels linked to HBsAg decline during TDF treatment

IP10 levels linked to HBsAg decline during TDF treatment

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array Biopharma reports strong fourth quarter and full year 2015 financial results

New research identifies potential treatment for primary effusion lymphoma

New research identifies potential treatment for primary effusion lymphoma

Hepatic ALT flares linked to HBsAg clearance

Hepatic ALT flares linked to HBsAg clearance

New Christian Doppler Laboratory for Complement Research opens at MedUni Vienna

New Christian Doppler Laboratory for Complement Research opens at MedUni Vienna

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.